Cutler Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-60
| Closed | -$2.67K | – | 3763 |
|
|
2023
Q2 | $2K | Buy |
60
+12
| +25% | +$679 | ﹤0.01% | 2956 |
|
|
2023
Q1 | $3K | Buy |
+48
| New | +$4.66K | ﹤0.01% | 2906 |
|
|
2022
Q3 | – | Sell |
-36
| Closed | -$7K | – | 4888 |
|
|
2022
Q2 | $7K | Buy |
+36
| New | +$5.88K | ﹤0.01% | 3428 |
|
|
2021
Q4 | – | Sell |
-12
| Closed | -$5K | – | 5351 |
|
|
2021
Q3 | $5K | Hold |
12
| – | – | ﹤0.01% | 4412 |
|
|
2021
Q2 | $4K | Hold |
12
| – | – | ﹤0.01% | 4544 |
|
|
2021
Q1 | $4K | Hold |
12
| – | – | ﹤0.01% | 4466 |
|
|
2020
Q4 | $5K | Sell |
12
-8
| -40% | -$3.69K | ﹤0.01% | 3614 |
|
|
2020
Q3 | $6K | Buy |
+20
| New | +$6.81K | ﹤0.01% | 3320 |
|
|
2020
Q2 | – | Sell |
-28
| Closed | -$7.07K | – | 4357 |
|
|
2020
Q1 | $5K | Buy |
+28
| New | +$8.89K | ﹤0.01% | 3048 |
|
|
2018
Q1 | – | Sell |
-20
| Closed | -$18.2K | – | 4421 |
|
|
2017
Q4 | $9K | Sell |
20
-84
| -81% | -$31K | ﹤0.01% | 3187 |
|
|
2017
Q3 | $43K | Sell |
104
-8
| -7% | -$3.02K | ﹤0.01% | 2370 |
|
|
2017
Q2 | $39K | Buy |
112
+32
| +40% | +$12.3K | ﹤0.01% | 2737 |
|
|
2017
Q1 | $41K | Buy |
80
+76
| +1,900% | +$31.5K | ﹤0.01% | 2605 |
|
|
2016
Q4 | $1K | Sell |
4
-28
| -88% | -$11.9K | ﹤0.01% | 5881 |
|
|
2016
Q3 | $17K | Hold |
32
| – | – | ﹤0.01% | 3575 |
|
|
2016
Q2 | $18K | Buy |
+32
| New | +$15.4K | ﹤0.01% | 3462 |
|
|
2016
Q1 | – | Sell |
-12
| Closed | -$5.4K | – | 6446 |
|
|
2015
Q4 | $7K | Buy |
+12
| New | +$9.08K | ﹤0.01% | 4503 |
|
Other funds holding ATRA
EC
RG
